Jay Bae

1.1k total citations
51 papers, 713 citations indexed

About

Jay Bae is a scholar working on Endocrinology, Diabetes and Metabolism, Economics and Econometrics and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Jay Bae has authored 51 papers receiving a total of 713 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Endocrinology, Diabetes and Metabolism, 14 papers in Economics and Econometrics and 13 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Jay Bae's work include Diabetes Treatment and Management (19 papers), Diabetes Management and Research (17 papers) and Health Systems, Economic Evaluations, Quality of Life (12 papers). Jay Bae is often cited by papers focused on Diabetes Treatment and Management (19 papers), Diabetes Management and Research (17 papers) and Health Systems, Economic Evaluations, Quality of Life (12 papers). Jay Bae collaborates with scholars based in United States, United Kingdom and Germany. Jay Bae's co-authors include Maureen J. Lage, Byron J. Hoogwerf, Kristina S. Boye, David R. Nelson, Daojun Mo, Anthony J. Zagar, Patrick L. McCollam, Tessa Kennedy‐Martin, Emily Freeman and Rosirene Paczkowski and has published in prestigious journals such as BMC Public Health, Obesity and Journal of Health Economics.

In The Last Decade

Jay Bae

46 papers receiving 685 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jay Bae United States 15 271 175 153 112 104 51 713
Simon J. Griffin United Kingdom 13 543 2.0× 188 1.1× 169 1.1× 62 0.6× 42 0.4× 19 1.1k
Joanna Huang United States 17 247 0.9× 332 1.9× 97 0.6× 131 1.2× 62 0.6× 37 859
D. K. G. Andersson Sweden 14 395 1.5× 135 0.8× 130 0.8× 68 0.6× 55 0.5× 23 917
A. D. Morris United Kingdom 13 634 2.3× 121 0.7× 141 0.9× 143 1.3× 33 0.3× 19 990
Hermione Price United Kingdom 15 719 2.7× 94 0.5× 132 0.9× 144 1.3× 45 0.4× 50 1.0k
Jens Bos Netherlands 18 98 0.4× 107 0.6× 73 0.5× 78 0.7× 92 0.9× 74 834
Irene Marzona Italy 14 144 0.5× 440 2.5× 205 1.3× 28 0.3× 105 1.0× 25 826
Deborah Taira Juarez United States 15 245 0.9× 97 0.6× 126 0.8× 42 0.4× 89 0.9× 34 682
Sipke T. Visser Netherlands 15 96 0.4× 155 0.9× 62 0.4× 112 1.0× 82 0.8× 28 641
Rogério Baumgratz de Paula Brazil 17 166 0.6× 272 1.6× 90 0.6× 209 1.9× 35 0.3× 63 983

Countries citing papers authored by Jay Bae

Since Specialization
Citations

This map shows the geographic impact of Jay Bae's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jay Bae with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jay Bae more than expected).

Fields of papers citing papers by Jay Bae

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jay Bae. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jay Bae. The network helps show where Jay Bae may publish in the future.

Co-authorship network of co-authors of Jay Bae

This figure shows the co-authorship network connecting the top 25 collaborators of Jay Bae. A scholar is included among the top collaborators of Jay Bae based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jay Bae. Jay Bae is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bae, Jay, David R. Nelson, Kristina S. Boye, & Kieren J. Mather. (2025). Prevalence of complications and comorbidities associated with obesity: a health insurance claims analysis. BMC Public Health. 25(1). 273–273. 3 indexed citations
2.
3.
Bae, Jay, Lee Kallenbach, David R. Nelson, et al.. (2024). Obesity and metabolic syndrome in patients with heart failure with preserved ejection fraction: a cross-sectional analysis of the Veradigm Cardiology Registry. BMC Endocrine Disorders. 24(1). 59–59. 4 indexed citations
4.
Kan, Hong, Jay Bae, Julia P. Dunn, et al.. (2023). Real-world primary nonadherence to antiobesity medications. Journal of Managed Care & Specialty Pharmacy. 29(10). 1099–1108. 8 indexed citations
5.
Ford, Janet H., et al.. (2023). Five-year morbidity and mortality rates in a U.S. population with obesity with and without prediabetes. Journal of Diabetes and its Complications. 37(5). 108454–108454. 3 indexed citations
6.
Boye, Kristina S., Jay Bae, Vivian T. Thieu, & Maureen J. Lage. (2023). An Economic Evaluation of the Relationship Between Glycemic Control and Total Healthcare Costs for Adults with Type 2 Diabetes: Retrospective Cohort Study. Diabetes Therapy. 15(2). 395–407. 2 indexed citations
7.
Benedict, Ágnes, Emily R. Hankosky, Jieling Chen, et al.. (2022). A Framework for Integrating Continuous Glucose Monitor-Derived Metrics into Economic Evaluations in Type 1 Diabetes. PharmacoEconomics. 40(8). 743–750. 1 indexed citations
8.
Boye, Kristina S., et al.. (2021). Obesity and glycemic control among people with type 2 diabetes in the United States: A retrospective cohort study using insurance claims data. Journal of Diabetes and its Complications. 35(9). 107975–107975. 26 indexed citations
9.
Boye, Kristina S., Maureen J. Lage, Shraddha Shinde, Vivian T. Thieu, & Jay Bae. (2021). Trends in HbA1c and Body Mass Index Among Individuals with Type 2 Diabetes: Evidence from a US Database 2012–2019. Diabetes Therapy. 12(7). 2077–2087. 29 indexed citations
10.
Simeone, Jason C., Jay Bae, Byron J. Hoogwerf, et al.. (2017). Clinical course of nonalcoholic fatty liver disease: an assessment of severity, progression, and outcomes. Clinical Epidemiology. Volume 9. 679–688. 27 indexed citations
11.
Peng, Xiaomei, et al.. (2016). Treatment progression in sulfonylurea and dipeptidyl peptidase-4-inhibitor cohorts of type 2 diabetes patients on metformin. Patient Preference and Adherence. Volume 10. 1539–1546. 2 indexed citations
12.
Bognar, Katalin, et al.. (2016). The role of imperfect surrogate endpoint information in drug approval and reimbursement decisions. Journal of Health Economics. 51. 1–12. 10 indexed citations
13.
Smith‐Palmer, Jayne, Jay Bae, Kristina S. Boye, et al.. (2016). Evaluating health-related quality of life in type 1 diabetes: a systematic literature review of utilities for adults with type 1 diabetes. ClinicoEconomics and Outcomes Research. Volume 8. 559–571. 39 indexed citations
14.
Bae, Jay, Maureen J. Lage, Daojun Mo, David R. Nelson, & Byron J. Hoogwerf. (2015). Obesity and glycemic control in patients with diabetes mellitus: Analysis of physician electronic health records in the US from 2009–2011. Journal of Diabetes and its Complications. 30(2). 212–220. 102 indexed citations
15.
Smith‐Palmer, Jayne, Jay Bae, Kristina S. Boye, Magaly Perez‐Nieves, & William J. Valentine. (2014). Traditional And Non-Traditional Risk Factors For Cardiovascular Disease In Type 2 Diabetes: Systematic Review Of Longitudinal Studies. Value in Health. 17(7). A478–A478. 2 indexed citations
16.
Bae, Jay, Paul P. Dobesh, Donald G. Klepser, et al.. (2012). Adherence and dosing frequency of common medications for cardiovascular patients.. PubMed. 18(3). 139–46. 61 indexed citations
17.
18.
Buck, Jeffrey A., Judith L. Teich, Jay Bae, & Joan Dilonardo. (2001). Mental Health and Substance Abuse Services in Ten State Medicaid Programs. Administration and Policy in Mental Health and Mental Health Services Research. 28(3). 181–192. 14 indexed citations
19.
Frank, Richard G., et al.. (1997). Solutions for adverse selection in behavioral health care.. PubMed. 18(3). 109–22. 33 indexed citations
20.
Bae, Jay. (1997). Assessing the need, use, and developments in mental health/substance abuse care.. PubMed. 18(3). 1–4. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Simon J. Griffin Breakdown of academic impact, for papers by Joanna Huang Breakdown of academic impact, for papers by D. K. G. Andersson Breakdown of academic impact, for papers by A. D. Morris Breakdown of academic impact, for papers by Hermione Price Breakdown of academic impact, for papers by Jens Bos Breakdown of academic impact, for papers by Irene Marzona Breakdown of academic impact, for papers by Deborah Taira Juarez Breakdown of academic impact, for papers by Sipke T. Visser Breakdown of academic impact, for papers by Rogério Baumgratz de Paula
Rankless by CCL
2026